ARKG Holdings of CRISPR Therapeutics (CRSP) - Updated Daily
TherapeuticsGene TherapyCAR-T Cell TherapyCRSPR Gene Editing
Key Statistics
Statistics
| ⚖️Weighting | 🧢Market Cap |
|---|---|
| 7.04% | $4.58b |
| 🏋🏿♂️Weight Rank In ARKG | 🌏Country |
| 1 | 🇨🇭Switzerland |
| 🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
| 7 | $70.01 |
| 🎫ARK Ownership Percent | |
| 2.05% | |
Other ETFs That Hold CRSP
Research Notes and Commentary for CRSP
No Research Notes Found for CRSP